Original author: 0xFacai
Reposted by: Luke, Mars Finance
On December 23, Binance announced that Binance Launchpool will launch its 63rd project, BIO Protocol (BIO), and trading pairs such as BIO/USDT and BIO/BNB will be available from January 3, 2025. According to Binance's announcement, the total supply of the genesis token for BIO Protocol is 3,320,000,000 tokens, with an initial circulating supply of 1,296,529,168 tokens at the time of listing, accounting for approximately 39.05% of the total genesis token supply. Of these, 56% of BIO tokens will be allocated to the ecosystem and community, 25.4% to early contributors, and 18.6% to early supporters.
Since Binance Labs announced its investment in BIO Protocol, the DeSci market has reignited, with related concept tokens such as VITA, GROW, and RSC experiencing significant increases. Following the news from Binance Launchpool, recent popular ecological meme coins have also surged rapidly, with RIF briefly rising over 40%, URO over 35%, and DRUGS over 150%. Additionally, established DeSci tokens like VITA and RSC have begun to show market reactions.
In this article, BlockBeats comprehensively reviews the current BIO ecosystem and potential targets related to DeSci concepts, including DAOs, NFTs, and meme coins, indicating that there are ample speculative opportunities in the DeSci field.
BIO ecosystem DeSci DAO
BIO is a network of biological DAOs, each focused on developing research and products in specific scientific fields. Currently, the BIO network consists of eight different scientific communities focusing on areas such as longevity, women's health, neurodegenerative diseases, and synthetic biology. The background and mechanisms of BIO Protocol will not be elaborated on further in this article.
Initial DeSci DAO
The initial DeSci DAO was established before BIO Protocol separated from Molecule, and currently, there are 7 of them. After the establishment of BIO Protocol, these DAO organizations were first incorporated into the BIO network. During the previous BIO Genesis Event, users also had to exchange tokens from these DAO organizations for BIO tokens, so these DAO tokens are also part of the BIO network assets.
VitaDAO: Secured over $5 million in funding in the field of longevity science, supported by Pfizer's venture capital division and Balaji Srinivasan, and is a decentralized scientific organization collaborating with Newcastle University. It is worth noting that VitaDAO is the 'elder among elders', the first DeSci DAO founded by Molecule, the mother of BIO Protocol, focusing on research in the field of longevity. The current BIO Protocol association is also a Swiss nonprofit organization founded by key members of VitaDAO.
HairDAO: Focused on hair loss; the DAO owns patents and consumer products Follicool.
CerebrumDAO: Promoting brain health, has raised over $1.5 million and has reached agreements with Fission Pharma to address mitochondrial dysfunction in neurodegenerative diseases.
ValleyDAO: Focused on synthetic biology, has raised over $2 million and is collaborating with Imperial College London.
AthenaDAO: Promoting women's health R&D, providing $500,000 in funding for translational research, with 14 intellectual property transactions pending.
CryoDAO: Promoting the development of cryobiology, has raised over $3 million for the field and established projects with Oxford Cryogenic Technologies and Advanced Neurobiology.
PsyDAO: Focused on psychedelic drugs, has launched a new platform OPSY utilizing psychedelic drug trials and data.
The first batch of Launchpad DAOs
Recently, BIO Protocol announced the first batch of Launchpad DAOs after their launch. These DAOs were launched through the auction mechanism of the BIO platform's Launchpad. Among them, the first DAO to conduct token auctions was Quantum Biology DAO, which completed its auction on December 17, with bidding being very competitive, with the starting price exceeding the original price by over ten times.
Long COVID Labs: Accelerating the cure for over 100 million Long COVID patients. Founded by Rohan Dixit, a former Stanford neuroscientist, healthcare entrepreneur, and Long COVID survivor.
Quantum Biology DAO: Manufacturing quantum microscopes to advance biological research. The founders are Clarice D. Aiello (MIT Ph.D., a world-leading quantum biology scientist) and Geoff Anders (Executive Director of Leverage Research).
Curetopia (Rare Diseases): Addressing the field of rare diseases worth over $10,000 by uniting families and patient communities. Founded by Ethan Perlstein, a Harvard Ph.D., entrepreneur, and Y-Combinator alumnus.
BIO series meme & AI DAO
In addition to serious research DAO organizations, the BIO team and community have also conducted interesting DeSci experiments outside of DeSci DAOs, successfully bringing significant attention to the DeSci field.
RIF/URO
Pump.Science is a meme token platform launched by BIO Protocol at this year's Token 2049 Solana Breakpoint conference, where players can purchase meme tokens representing drugs and participate in the prediction of drug effects and trading of experimental data. The recent surge of RIF/URO after DEVCON Bangkok has also ignited the DeSci field, which has been viewed by the market as the leading speculative target in the DeSci field for a long time.
DRUGS
DRUGS (Big Pharma) is also known as 'Little BIO', and is the 'favorite child' of the BIO Protocol ecosystem. DRUGS aims to disrupt the monopolistic business model of traditional large pharmaceutical companies, and the project has received widespread support from the BIO ecosystem since its inception, including Pump Science, other BIO-related DeSci DAOs, and BIO co-founder Paul himself.
GIRLE/BABY
GIRLE and BABY are AI DAOs and meme tokens issued by AthenaDAO on the Solana DAOs.fun platform and Base chain, both supporting scientific research in the field of women's fertility.
Among them, GIRLE aims to empower the future of fertility through AI and Web3, and the team is currently conducting related experiments on peptide cell repair, testing the effects of peptides on cells, and will soon launch related experimental tokens. Their official website also showcases other token holdings in the DAO treasury.
BIO ecosystem IPT
IPT is an intellectual property token pioneered by the Molecule Catalyst platform, representing partial governance rights over generated research IP. These tokens give holders the opportunity to directly participate in the development, decision-making, and future direction of research. Each BioDAO typically holds a portfolio of IP tokens representing intellectual property related to specific scientific research fields of the BioDAO. Currently, the most recognized IPTs are VitaRNA and VITA-FAST developed and owned by VitaDAO.
IPT VitaRNA & VITA-FAST
VitaRNA is the IPT of Artan Bio, a gene therapy project that has raised over $300,000. Artan Bio is exploring promising gene therapy fields that help address genetic factors related to aging. The company's approach aims to develop therapeutic candidates that may suppress mutations leading to aging. Artan Bio is led by two entrepreneurs who previously advanced a drug development platform to human clinical trials.
VITA-FAST is the IPT of Viktor Korolchuk's laboratory, which also successfully raised over $300,000. VITA-FAST focuses on research into drugs that enhance autophagy, which is the natural 'waste disposal' built into our body cells that can eliminate unnecessary protein accumulation.
OVARIA
OVARIA is the IPT launched in collaboration between AthenaDAO and Gero. Gero is a biotechnology company that uses artificial intelligence for target and drug discovery, and AthenaDAO collaborates with Gero to revolutionize the treatment landscape for ovarian aging, providing therapeutic potential in currently limited areas. AthenaDAO will use their platform to identify up to 10 new targets for ovarian aging, with trial results expected to delay menopause and reduce its health-related consequences.
Competitors & related memes
In addition to BIO-related targets, the ecological heat also extends to other fields of DeSci.
RSC
Research Hub is a DeSci project founded by Coinbase CEO Brian Armstrong, aimed at accelerating the pace of scientific research. By creating modern mobile and web applications, it allows people to conduct scientific research more effectively.
On the ResearchHub platform, research papers are stored and grouped by research field in 'centers'. The personal center will essentially act as an on-site journal in key areas, with posts that receive high voting moving to the top of each center (i.e., the papers and their related abstracts and discussions).
Scihub
Inspired by Sci-hub, the world's largest free paper download center, which faces legal issues due to its open-source nature and relies solely on donations to maintain the platform. 0xAA (@0xAA_Science) is the top holder of this token, currently holding 22% of the total tokens, and he has stated that he will donate 20% of the tokens to the operators of SciHub in support of their mission and platform development.
Currently, BIO Protocol has announced its roadmap for 2025, including:
BIO token will have its TGE on the Ethereum mainnet on January 3.
BIO tokens will be launched on Solana and Base networks;
New BioDAO launched;
BIO/BioDAO liquidity pool;
The new BIO Launchpad is officially online.
With the BIO token listing on Binance, the DeSci field may usher in a new wave of excitement.
